ArticleInternational journal of cardiology. Heart & vasculature2025
AI-based measurement of cardiothoracic ratio in chest X-rays and prediction of echocardiographic congestive heart failure.
Article in International journal of cardiology. Heart & vasculature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictors of echocardiographic abnormalities in asymptomatic individuals with increased cardiothoracic ratio detected on chest radiography.American heart journal plus : cardiology research and practice · 2026Article
- A bibliometric analysis of artificial intelligence applications in heart failure.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study presents an artificial intelligence (AI) model for automated cardiothoracic ratio (CTR) measurement from chest X-rays (CXRs) and evaluates its association with severe left ventricular hypertrophy (SLVH) and dilated left ventricle (DLV) diagnosed by echocardiography. The study also assesses CTR's prognostic value for predicting future SLVH/DLV development. Methods: In this retrospective cohort study, an AI algorithm measured CTR on 71,129 CXRs from 24,673 patients from 2013 to 2018 in the CheXchoNet database. SLVH/DLV was defined using echocardiographic criteria. Diagnostic accuracy was assessed using AUROC and AUPRC alongside sensitivity and specificity at various CTR thresholds. Logistic regression was performed for CXR-echocardiogram pairs. Time-to-event analysis was performed on 9,890 patients without baseline SLVH/DLV. Results: Among 24,673 patients (mean age: 62.1 years; female sex: 56.9 %), mean CTR was higher in SLVH/DLV patients (0.56 ± 0.07) than those without (0.52 ± 0.07; p < 0.001). AUROC was 0.70 (95 % CI: 0.69-0.70). At a CTR threshold of 0.53, sensitivity was 70 % and specificity 60 %. Increased CTR was associated with SLVH/DLV risk on paired echocardiogram, with an odds ratio of 1.26 at a CTR of 0.65 compared to CTR at 0.50 (95 % CI: 1.24-1.27, p < 0.001). Time-to-event analysis on patients without baseline SLVH/DLV showed patients with baseline CTR > 0.65 had a 4.13-fold increased risk of developing SLVH/DLV in the future compared to patients with CTR ≤ 0.50 (adjusted HR: 4.13; 95 % CI: 2.48-6.89; p < 0.01). Conclusion: AI-based CTR measurement helps predict SLVH/DLV and could be used for risk stratification for cardiovascular care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.